Updated Jul 16, 2026 · Last SEC filing 2026-07-02
Faeth Therapeutics, Inc. (FTH) has filed 13 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 6 Form 8-K material event filings were reported by FTH in the last 90 days. 1 Form 144 notices of proposed sale were filed for FTH stock. InsiderAlpha tracks every FTH SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001829802 |
|---|
| Form 4 filings (90d) | 13 |
|---|---|
| Form 8-K filings (90d) | 6 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 4.4K | $23.40 | $103K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 600 | $24.22 | $15K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 1.6K | $23.88 | $39K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 4.3K | $24.98 | $106K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 1.9K | $22.95 | $44K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 831 | $23.34 | $19K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 1.4K | $25.55 | $35K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 580 | $23.61 | $14K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 4.2K | $24.90 | $105K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 100 | $26.39 | $3K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 2.9K | $25.22 | $73K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 3.0K | $25.98 | $78K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 3.4K | $26.98 | $92K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 100 | $27.77 | $3K | SEC | |
| STEPHENSON BRIAN C | Chief Financial Officer | P — Open-market purchase | 2.0K | $24.84 | $49K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Faeth Therapeutics, Inc. (FTH). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| STEPHENSON BRIAN C | 22 | $1.13M |
| MILLENNIUM MANAGEMENT LLC | 17 | $679K |
| Parikh Anand Kiran | 8 | $117K |
| Hahn Stephen M. | 3 | — |
| Cambrian BioPharma Inc | 2 | $501K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in FTH insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live FTH dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.